Sulfacetamide sodium + Prednisolone sodium phosphate Ophthalmic Solution Rx
Generic Name and Formulations:
Sulfacetamide sodium 100mg, prednisolone sodium phosphate 2.5mg; per mL; contains thimersol.
Various generic manufacturers
Indications for Sulfacetamide sodium + Prednisolone sodium phosphate Ophthalmic Solution:
For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists.
Adults and Children:
<6yrs: not established. ≥6yrs: instill 2 drops in the eye(s) every 4 hours. Max initial ℞: 20mL.
Ocular fungal, viral or mycobacterial infections.
Do not inject into the eye. Corneal or scleral thinning. Severe dry eye. Glaucoma. Monitor IOP, and for secondary infections in prolonged use. Discontinue if sensitization reaction occurs. Reevaluate if symptoms fail to improve after two days. Pregnancy (Cat.C). Nursing mothers: not recommended.
Antibacterial + steroid.
Incompatible with silver preparations. Local anesthetics related to p-aminobenzoic acid may antagonize the action of sulfonamide.
Local irritation, sensitization, masks infection, delays healing; in prolonged use: increased IOP, cataracts, corneal perforation, optic nerve damage.
Formerly known under the brand name Vasocidin.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Models Predict Intracerebral Hemorrhage Growth
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy